These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 18436346

  • 1. Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities.
    Kumar A, Ahmad P, Maurya RA, Singh AB, Srivastava AK.
    Eur J Med Chem; 2009 Jan; 44(1):109-16. PubMed ID: 18436346
    [Abstract] [Full Text] [Related]

  • 2. Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.
    Kumar A, Maurya RA, Sharma S, Ahmad P, Singh AB, Tamrakar AK, Srivastava AK.
    Bioorg Med Chem; 2009 Jul 15; 17(14):5285-92. PubMed ID: 19500993
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice.
    Kumar A, Sharma S, Gupta LP, Ahmad P, Srivastava SP, Rahuja N, Tamrakar AK, Srivastava AK.
    Bioorg Med Chem; 2012 Mar 15; 20(6):2172-9. PubMed ID: 22341243
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G, Paoli P, León-Rivera I, Villalobos-Molina R, Medina-Franco JL, Ortiz-Andrade R, Estrada-Soto S, Camici G, Diaz-Coutiño D, Gallardo-Ortiz I, Martinez-Mayorga K, Moreno-Díaz H.
    Bioorg Med Chem; 2009 May 01; 17(9):3332-41. PubMed ID: 19362487
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of 2,4-disubstituted polyhydroquinolines as prospective antihyperglycemic and lipid modulating agents.
    Kumar A, Sharma S, Tripathi VD, Maurya RA, Srivastava SP, Bhatia G, Tamrakar AK, Srivastava AK.
    Bioorg Med Chem; 2010 Jun 01; 18(11):4138-48. PubMed ID: 20471838
    [Abstract] [Full Text] [Related]

  • 6. Pyranocoumarins: a new class of anti-hyperglycemic and anti-dyslipidemic agents.
    Kumar A, Maurya RA, Sharma S, Ahmad P, Singh AB, Bhatia G, Srivastava AK.
    Bioorg Med Chem Lett; 2009 Nov 15; 19(22):6447-51. PubMed ID: 19811915
    [Abstract] [Full Text] [Related]

  • 7. Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
    Ramírez-Espinosa JJ, Rios MY, López-Martínez S, López-Vallejo F, Medina-Franco JL, Paoli P, Camici G, Navarrete-Vázquez G, Ortiz-Andrade R, Estrada-Soto S.
    Eur J Med Chem; 2011 Jun 15; 46(6):2243-51. PubMed ID: 21453996
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of protein tyrosine phosphatase 1B inhibitors: model validation and docking studies.
    Saxena AK, Pandey G, Gupta S, Singh AB, Srivastava AK.
    Bioorg Med Chem Lett; 2009 Apr 15; 19(8):2320-3. PubMed ID: 19282172
    [Abstract] [Full Text] [Related]

  • 9. Antihyperglycemic activity of compounds isolated from Indian medicinal plants.
    Akanksha, Srivastava AK, Maurya R.
    Indian J Exp Biol; 2010 Mar 15; 48(3):294-8. PubMed ID: 21046984
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors.
    Gupta S, Pandey G, Rahuja N, Srivastava AK, Saxena AK.
    Bioorg Med Chem Lett; 2010 Oct 01; 20(19):5732-4. PubMed ID: 20797859
    [Abstract] [Full Text] [Related]

  • 11. Antihyperglycemic activity of 2-methyl-3,4,5-triaryl-1H-pyrroles in SLM and STZ models.
    Goel A, Agarwal N, Singh FV, Sharon A, Tiwari P, Dixit M, Pratap R, Srivastava AK, Maulik PR, Ram VJ.
    Bioorg Med Chem Lett; 2004 Mar 08; 14(5):1089-92. PubMed ID: 14980641
    [Abstract] [Full Text] [Related]

  • 12. 5,6-Diarylanthranilo-1,3-dinitriles as a new class of antihyperglycemic agents.
    Singh FV, Parihar A, Chaurasia S, Singh AB, Singh SP, Tamrakar AK, Srivastava AK, Goel A.
    Bioorg Med Chem Lett; 2009 Apr 15; 19(8):2158-61. PubMed ID: 19303291
    [Abstract] [Full Text] [Related]

  • 13. Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor γ selective agonists with protein-tyrosine phosphatase 1B inhibition.
    Otake K, Azukizawa S, Fukui M, Kunishiro K, Kamemoto H, Kanda M, Miike T, Kasai M, Shirahase H.
    Bioorg Med Chem; 2012 Jan 15; 20(2):1060-75. PubMed ID: 22197396
    [Abstract] [Full Text] [Related]

  • 14. Novel substituted naphthalen-1-yl-methanone derivatives as anti-hyperglycemic agents.
    Kumar A, Pathak SR, Ahmad P, Ray S, Tewari P, Srivastava AK.
    Bioorg Med Chem Lett; 2006 May 15; 16(10):2719-23. PubMed ID: 16500101
    [Abstract] [Full Text] [Related]

  • 15. Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice.
    Jiang B, Guo S, Shi D, Guo C, Wang T.
    Eur J Med Chem; 2013 Jun 15; 64():129-36. PubMed ID: 23644196
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, characterization, and antihyperglycemic activity of novel oxazolidine derivatives.
    Selvam TP, Kumar PV, Ramu P, Kumar AS.
    Arch Pharm Res; 2011 Jun 15; 34(6):887-91. PubMed ID: 21725808
    [Abstract] [Full Text] [Related]

  • 17. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.
    Cobb JE, Blanchard SG, Boswell EG, Brown KK, Charifson PS, Cooper JP, Collins JL, Dezube M, Henke BR, Hull-Ryde EA, Lake DH, Lenhard JM, Oliver W, Oplinger J, Pentti M, Parks DJ, Plunket KD, Tong WQ.
    J Med Chem; 1998 Dec 03; 41(25):5055-69. PubMed ID: 9836622
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and in vivo antihyperglycemic activity of nature-mimicking furanyl-2-pyranones in STZ-S model.
    Singh FV, Chaurasia S, Joshi MD, Srivastava AK, Goel A.
    Bioorg Med Chem Lett; 2007 May 01; 17(9):2425-9. PubMed ID: 17336063
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Flavone-based novel antidiabetic and antidyslipidemic agents.
    Verma AK, Singh H, Satyanarayana M, Srivastava SP, Tiwari P, Singh AB, Dwivedi AK, Singh SK, Srivastava M, Nath C, Raghubir R, Srivastava AK, Pratap R.
    J Med Chem; 2012 May 24; 55(10):4551-67. PubMed ID: 22524508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.